Tourmaline Bio shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Tourmaline Bio
Tip: Access up to 7 years of quarterly data
All positions including Tourmaline Bio held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tourmaline Bio by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $621k | 13k | 47.83 |
| 2025-06-30 | $270k | 17k | 15.99 |
| 2024-06-30 | $404k | 31k | 12.86 |
| 2024-03-31 | $204k | 8.9k | 22.90 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas